142 related articles for article (PubMed ID: 30542453)
1. Endothelial PAS domain protein 1 gene hypomethylation is associated with colorectal cancer in Han Chinese.
Pan R; Zhou C; Dai J; Ying X; Yu H; Zhong J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Zhang W; Duan S
Exp Ther Med; 2018 Dec; 16(6):4983-4990. PubMed ID: 30542453
[TBL] [Abstract][Full Text] [Related]
2. Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese.
Zhong J; Pan R; Ying X; Wu B; Zhou C; Wu D; Ying J; Duan S
Pathol Res Pract; 2019 Mar; 215(3):532-538. PubMed ID: 30638951
[TBL] [Abstract][Full Text] [Related]
3. Significant association of PRMT6 hypomethylation with colorectal cancer.
Pan R; Yu H; Dai J; Zhou C; Ying X; Zhong J; Zhao J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Duan S
J Clin Lab Anal; 2018 Nov; 32(9):e22590. PubMed ID: 29927001
[TBL] [Abstract][Full Text] [Related]
4. FANCF hypomethylation is associated with colorectal cancer in Han Chinese.
Yu H; Pan R; Gao T; Wu D; Ying J; Duan S
Turk J Gastroenterol; 2020 Aug; 31(8):558-565. PubMed ID: 32915143
[TBL] [Abstract][Full Text] [Related]
5. Significant association of
Ying X; Pan R; Zhong J; Wu B; Jiang Y; Ying J; Zhou C; Dai J; Zhao S; Shen Y; Zhang W; Duan S
Oncol Lett; 2019 Aug; 18(2):1564-1570. PubMed ID: 31423224
[TBL] [Abstract][Full Text] [Related]
6. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.
Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M
Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434
[TBL] [Abstract][Full Text] [Related]
7.
Zhou C; Pan R; Hu H; Li B; Dai J; Ying X; Yu H; Zhong J; Mao Y; Zhang Y; Wu D; Duan S
PeerJ; 2018; 6():e5336. PubMed ID: 30225159
[TBL] [Abstract][Full Text] [Related]
8. Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer.
Li D; Bai Y; Feng Z; Li W; Yang C; Guo Y; Lin C; Zhang Y; He Q; Hu G; Li X
Front Oncol; 2019; 9():394. PubMed ID: 31165042
[TBL] [Abstract][Full Text] [Related]
9. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
[TBL] [Abstract][Full Text] [Related]
10. The role of
Hu H; Chen X; Wang C; Jiang Y; Li J; Ying X; Yang Y; Li B; Zhou C; Zhong J; Wu D; Ying J; Duan S
Oncotarget; 2017 Oct; 8(48):84054-84065. PubMed ID: 29137404
[TBL] [Abstract][Full Text] [Related]
11.
Zhang M; Li J; Lin W; Qi L; Yao C; Zheng Z; Chen C; Duan S; Qi Y
Genet Test Mol Biomarkers; 2022; 26(7-8):360-374. PubMed ID: 35920832
[No Abstract] [Full Text] [Related]
12. Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma.
Xia G; Kageyama Y; Hayashi T; Kawakami S; Yoshida M; Kihara K
Cancer; 2001 Apr; 91(8):1429-36. PubMed ID: 11301389
[TBL] [Abstract][Full Text] [Related]
13. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
[TBL] [Abstract][Full Text] [Related]
14. CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population.
Li B; Chen X; Jiang Y; Yang Y; Zhong J; Zhou C; Hu H; Duan S
Immunol Lett; 2017 Oct; 190():15-19. PubMed ID: 28690186
[TBL] [Abstract][Full Text] [Related]
15. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
16. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer.
Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S
Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728
[TBL] [Abstract][Full Text] [Related]
18. LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
Nagai Y; Sunami E; Yamamoto Y; Hata K; Okada S; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Ishihara S; Hoon DS; Watanabe T
Oncotarget; 2017 Feb; 8(7):11906-11916. PubMed ID: 28060757
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
Kano H; Takayama T; Midorikawa Y; Nagase H
Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
